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Delayed ischemic preconditioning effectively protects
kidneys from ischemia–reperfusion injury but the mechanism
underlying renal protection remains poorly understood. Here
we examined the in vivo role of microRNA miR-21 in the renal
protection conferred by delayed ischemic preconditioning in
mice. A 15-min renal ischemic preconditioning significantly
increased the expression of miR-21 by 4h and substantially
attenuated ischemia–reperfusion injury induced 4 days later.
A locked nucleic acid–modified anti-miR-21 given at the time
of ischemic preconditioning knocked down miR-21 and
significantly exacerbated subsequent ischemia–reperfusion
injury in the mouse kidney. Knockdown of miR-21 resulted in
significant upregulation of programmed cell death protein 4,
a proapoptotic target gene of miR-21, and substantially
increased tubular cell apoptosis. Hypoxia-inducible factor-1a
in the kidney was activated after ischemic preconditioning
and blockade of its activity with a decoy abolished the
upregulation of miR-21 in cultured human renal epithelial
cells treated with the inducer cobalt chloride. In the absence
of ischemic preconditioning, knockdown of miR-21 alone did
not significantly affect ischemia–reperfusion injury in the
mouse kidney. Thus, upregulation of miR-21 contributes to
the protective effect of delayed ischemic preconditioning
against subsequent renal ischemia–reperfusion injury.
Kidney International (2012) 82, 1167–1175; doi:10.1038/ki.2012.241;
published online 11 July 2012
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MicroRNAs (miRNAs) are endogenous, small (18–22 nucleo-
tides) RNA molecules that have an important and ubiquitous
role in regulating gene expression. miRNAs typically bind to
the 30 untranslated region of their messenger RNA (mRNA)
targets and downregulate gene expression via mRNA degrada-
tion or translational inhibition.1–3 miRNAs are known to have
a significant role in cell physiological processes such as cell
differentiation,4 proliferation,5 and apoptosis.6 Emerging
evidence suggests that miRNAs could also be involved in
pathological processes in the kidney.7–9
Acute kidney injury is a common complication of major
surgical operations and sepsis resulting in adverse outcome.10
Ischemia–reperfusion (I/R) injury is the major cause of acute
kidney injury.11 However, a short period of ischemia followed
by reperfusion can activate endogenous defense mechanisms
that protect against a subsequent, sustained ischemic insult,
a phenomenon known as ischemic preconditioning (IPC).12
Recent data from us and other investigators indicate that in
kidney I/R injury, protective effects of IPC appear quickly
after IPC and dissipate over several hours but reappear several
days later.13–16 The latter phenomenon is defined as delayed
IPC. The protective mechanism of delayed IPC in the heart
and brain appears to involve a series of protective mediators
and/or effectors such as reactive oxygen species, protein kinase
C, hypoxia-inducible factor (HIF), inducible nitric oxide
synthase, heat shock protein 70, and so on.17,18 The beneficial
effects of delayed IPC require new protein synthesis and are
sustained for days to weeks.19 However, the mechanisms
underlying delayed IPC in the kidney are poorly understood.
In particular, the role of miRNAs in renal IPC is not
known. Several miRNAs such as miR-200, miR-24, and miR-
192 have been reported to be involved in cardiac, brain, and
hepatic IPC.20–22 These miRNAs were involved in the early
IPC. Yin et al.23 reported a possible role of miR-1, miR-21, and
miR-24 in an ex vivo model of late IPC in the mouse heart.
MiRNA miR-21 has been shown to be a strong
antiapoptotic factor at least in part by targeting proapoptotic
genes including programmed cell death protein 4
(PDCD4).24–26 Tubular cell apoptosis contributes importantly
to acute renal I/R injury.27 We therefore hypothesized that
miR-21 might have an important role in the renal protective
effect of delayed IPC. We used a mouse model of renal
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delayed IPC. With highly effective in vivo knockdown of miR-
21, we were able to determine the role of miR-21 in the renal
protection against I/R injury conferred by delayed IPC.
RESULTS
Delayed IPC protected mouse kidneys from I/R injury and
was associated with upregulation of miR-21
Mice were divided into two groups: an IPCþ I/R group and a
shamþ I/R group. The interval between IPC and I/R was 4
days. Mice in the IPCþ I/R group showed marked improve-
ment of renal function and histology compared with the
shamþ I/R group. Plasma creatinine levels at 24 h after
reperfusion were nearly 50% lower in the IPCþ I/R group
(Po0.05, Figure 1a). Histological examination in the
shamþ I/R group revealed characteristics of acute tubuloin-
terstitial damage, including massive tubular epithelial cell
necrosis or swelling, tubular casts, interstitial edema, and
inflammatory cell infiltration. Morphological damage was
most prominent in the outer medullary stripe, but also with
patchy involvement of the cortical proximal segments. In
contrast, renal morphology of preconditioned mice only
showed a mild-to-moderate degree of cell swelling (Figure 1b
and c). Apoptosis is characteristic of renal I/R injury. Delayed
IPC attenuated renal tubular cell apoptosis 24 h after I/R
(Figure 1d and e).
It is important to note that the I/R injury observed in the
present study was mild compared with the typical I/R injury
reported by others using the 30-min bilateral occlusion
method28 and by our own group using a related method.29
We suspect that this was because of a combination of several
technical factors such as the specific clamps and other
instruments used, and the operator. To ensure the robustness
of the study, we always studied control and experimental
groups in parallel, kept technical factors as consistent as
possible, and used multiple indices of injury (plasma
creatinine, histology score, and apoptosis).
Expression levels of miR-21 were significantly higher in
the kidneys from the IPCþ I/R group than the shamþ I/R
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Figure 1 |Delayed ischemic preconditioning (IPC) protected mouse kidneys from ischemia–reperfusion (I/R) injury and was
associated with the upregulation of miR-21. (a) Plasma creatinine and (b) renal acute tubulointerstitial injury score 24 h after I/R,
*Po0.05 vs. shamþ I/R. (c) Kidney sections were stained with periodic acid–Schiff and photographed at  20 magnification in the outer
medulla. Bar¼ 50mm. The black arrow indicates swelling of tubular epithelial cells. (d, e) Delayed IPC attenuated renal tubular cell apoptosis
24 h after I/R. Cell apoptosis was determined by terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling staining and
photographed at  20 magnification. Bar¼ 50mm, *Po0.05 vs. shamþ I/R. (f) miR-21 abundance 24 h after I/R was higher in kidneys
exposed to delayed IPC compared with sham. n¼ 6 per group; *Po0.05 vs. shamþ I/R. (g) miR-21 was upregulated at several time points
following IPC. n¼ 6 per group each time point; *Po0.05 vs. sham.
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group (Figure 1f). Time-course analysis indicated that miR-
21 was upregulated at 4 h after IPC compared with the sham
mice, and remained significantly higher 4 days after IPC
(Figure 1g). Expression levels of other injury-related
miRNAs, such as miR-320, miR-214, and let-7e, were not
statistically significantly upregulated at day 4 after IPC (data
not shown).
Knockdown of miR-21 exacerbated I/R injury in mouse
kidneys following delayed IPC
To determine the functional role of miR-21 in the renal
protection conferred by delayed IPC, locked nucleic acid
(LNA)–modified anti-scrambled or anti-miR-21 oligonucleo-
tides were administered to mice through the tail vein just
before the IPC surgery. All mice then underwent the IPC and,
4 days later, I/R procedures. As shown in Figure 2a, renal
levels of miR-21 expression, measured at 24 h after the I/R
injury (i.e., 5 days after the administration of LNA anti-miR),
were substantially reduced in mice receiving LNA anti-miR-
21. Plasma creatinine was significantly higher in mice
receiving anti-miR-21 compared with mice receiving the
scrambled anti-miR, suggesting that knockdown of miR-21
attenuated renal protection conferred by IPC (Figure 2b). As
shown in Figure 2c and d, kidneys from IPCþ I/R mice
receiving anti-miR-21 exhibited significant histological
damage including tubular casts, moderate inflammatory
infiltration, and cellular swelling. Renal histology of IPCþ I/
R mice receiving the scrambled anti-miR only showed mild-
to-moderate cellular swelling.
The increase of plasma creatinine shown in Figure 2b was
modest. To confirm the robustness of the observed effect of
anti-miR-21, we treated additional groups of mice with IPC
and anti-miR and measured plasma creatinine levels at 0, 1,
2, or 5 days following the I/R injury. Mice treated with
delayed IPC and the anti-scrambled oligonucleotides were
largely protected from the I/R injury (Figure 2e). Mice
treated with delayed IPC and anti-miR-21 showed clear
increases in plasma creatinine levels 1 and 2 days after the I/R
injury (Figure 2e). Note that experiments shown in Figure 2b
and e were conducted using different sets of clamps and other
instruments, and that separate groups of mice were used for
each time point shown in Figure 2e (instead of repeated
IPC+I/R scrambled control
(mg/dl)
*
60
80
100
120
a b c
d e
0
20
40
Scrambled
control
LNA anti-
miR-21
m
iR
-2
1 
ex
pr
es
sio
n
(%
 of
 sc
ram
ble
d c
on
tro
l)
*
0.15
0.2
0.25
0.3
0.35
0
0.05
0.1
Scrambled
control
LNA anti-
miR-21
Pl
as
m
a 
cr
ea
tin
in
e *2.5
3
1
1.5
2
0
0.5
Scrambled
control
LNA anti-
miR-21
H
is
to
lo
gy
 s
co
re
IPC + anti-scramble
IPC + anti-miR-21
*
*
(mg/dl)
Pl
as
m
a 
cr
ea
tin
in
e
0.8
0.5
0.6
0.7
0.1
0.2
0.3
0.4
Days following I/R
0
50 µm
654321
IPC+I/R LNA anti-miR-21
Figure 2 |Knockdown of miR-21 exacerbated ischemia–reperfusion (I/R) injury in mouse kidneys following delayed ischemic
preconditioning (IPC). (a) Locked nucleic acid (LNA) anti-miR-21 (10mg/kg), administered at the time of IPC, decreased miR-21 expression
effectively in the renal tissue examined 24 h after I/R (5 days after IPC). (b) Knockdown of miR-21 in mice exposed to delayed IPC significantly
increased plasma creatinine 24 h after I/R. (c) Knockdown of miR-21 in mice exposed to delayed IPC significantly worsened renal injury 24 h
after I/R, *Po0.05 vs. anti-scramble-treated mice. (d) Kidney sections were stained with periodic acid–Schiff and photographed at  20
magnification in the outer medulla. Bar¼ 50mm. The red arrow indicates infiltration of inflammatory cells. n¼ 6 for the anti-scramble-
treated group; n¼ 5 for the anti-miR-21-treated group. (e) Time course of plasma creatinine levels after I/R in mice exposed to delayed IPC
with or without miR-21 knockdown. Separate groups of mice were used for each time point. n¼ 3 for all time points, except n¼ 2 for the
5-day time point for anti-miR-21 and 0- and 2-day time points for anti-scrambled owing to the unexpected loss of mice; *Po0.05 vs.
anti-scramble-treated mice.
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blood sampling from the same mice), both of which
further supported the reproducibility of the observed effect
of anti-miR-21.
Knockdown of miR-21 upregulated proapoptotic target
gene PDCD4 and exacerbated apoptosis in mouse kidneys
following delayed IPC and I/R
We examined possible mechanisms mediating the protective
role of miR-21 in delayed IPC. It has been well established that
PDCD4 is a target gene of miR-21 and has powerful pro-
apoptotic effects.30–32 We examined PDCD4 protein expression
in IPCþ I/R mice receiving LNA anti-miR-21 or the scrambled
anti-miR. As shown in Figure 3a, PDCD4 protein expression
was upregulated by the anti-miR-21 treatment, consistent with
targeting of PDCD4 by miR-21. Concomitantly, IPCþ I/R
mice receiving the anti-miR-21 treatment exhibited a substan-
tially increased number of apoptotic tubular cells in the
kidney compared with IPCþ I/R mice receiving the scrambled
anti-miR (Figure 3b and c). The result suggests that
the protective effect of miR-21 might be in part mediated by
miR-21 targeting of PDCD4 and the resulting attenuation of
tubular cell apoptosis.
Several pathways, such as reduced phosphorylation of c-
Jun N-terminal kinase (JNK)16 and upregulation of inducible
nitric oxide synthase and heat shock protein 27,14 have been
established by others as playing a role in delayed IPC. JNK
activation has been shown to be an important inducer of
renal tubular apoptosis after ischemia.33 We examined the
levels of total JNK and phosphorylated JNK in the kidneys
following 24 h of I/R in the presence or absence of IPC and
with or without the anti-miR-21 treatment. We did not find
any significant effects of IPC or the anti-miR-21 treatment on
the level of JNK phosphorylation. However, we cannot rule
out the possibility that JNK activation was altered at earlier
time points after I/R as shown by Park et al.16
miR-21 was upregulated by activation of HIF
We went on to examine possible upstream mechanisms
leading to the upregulation of miR-21 following ischemia.
miR-21 has been shown to be responsive to hypoxia in cancer
cell lines,34 but it is not known whether miR-21 is actually
under the control of HIF. HIF-1a was activated in mouse
kidneys following IPC (Figure 4a). The accumulation of
nuclear HIF-1a was significantly increased 4 h after IPC and
persisted 4 days after IPC, compared with the sham mice.
Treatment of primary cultures of human renal epithelial
(HRE) cells with cobalt chloride or hypoxia, which are classic
inducers of HIF-1a activation, caused significant upregula-
tion of miR-21 (Figure 4b and c). Activation of HIF-1a by the
cobalt chloride treatment was confirmed by western blot in
nuclear extracts (Figure 4d). Double-stranded oligonucleo-
tides containing a HIF hypoxia-responsive element (HIF
decoy) were used to block the action of HIF. The HIF decoy,
compared with scrambled oligonucleotides, significantly
reduced miR-21 levels by 42% in HRE cells treated with
cobalt chloride (Figure 4e). HIF decoy significantly reduced
mRNA levels of erythropoietin, a prototypic HIF target gene,
to 64±8% of control (n¼ 6, Po0.05), confirming the
effectiveness of HIF blockade.
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Figure 3 |Knockdown of miR-21 resulted in upregulation of
proapoptotic target gene programmed cell death protein 4
(PDCD4) and exacerbated apoptosis in mouse kidneys
following delayed ischemic preconditioning (IPC) and
ischemia–reperfusion (I/R). (a) PDCD4 western blot showed that
locked nucleic acid (LNA) anti-miR-21 (10mg/kg), administered at
the time of IPC, increased PDCD4 expression in mouse renal tissue
24 h after I/R. (b) LNA anti-miR-21, administered at the time of IPC,
exacerbated renal tubular cell apoptosis 24 h after I/R. Cell
apoptosis was determined by terminal deoxynucleotidyl
transferase–mediated dUTP nick end labeling staining and
photographed at  20 magnification. Bar¼ 50 mm. The arrow
indicates apoptotic tubular cell. n¼ 6 for the anti-scramble-
treated group; n¼ 5 for the anti-miR-21-treated group; *Po0.05
vs. anti-scramble-treated mice.
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Knockdown of miR-21 did not affect I/R injury in the absence
of IPC
To examine whether miR-21 was protective in the absence of
IPC, we conducted two sets of experiments. First, we
administered LNA anti-miR-21 or the scrambled anti-miR
to mice just before I/R. The mice were not exposed to IPC.
The anti-miR-21, again, substantially reduced the level of
miR-21 in the kidney measured 24 h after I/R (Figure 5a).
However, plasma creatinine levels increased after 24-h
reperfusion similarly in both the anti-miR-21 and the
scrambled anti-miR groups (Figure 5b). Without IPC, I/R
induced significant renal histological damage including
tubular casts and inflammatory infiltration, as well as tubular
apoptosis. No significant difference in histology or apoptosis
was observed in mice receiving anti-miR-21 or the scrambled
anti-miR (Figure 5c–f).
In the second set of experiments, we administered LNA
anti-miR-21 or the scrambled anti-miR 4 days before the I/R
injury. The experiment mimicked the time course of the IPC
study without actually applying IPC. The anti-miR-21 treatment
substantially reduced the level of miR-21 in the kidney mea-
sured 24 h after I/R (Figure 5g). The treatment, however, did not
exacerbate renal I/R injury (Figure 5h) or significantly increase
apoptosis (Figure 5i and j), in contrast to the exacerbation of
injury by anti-miR-21 that we observed in the presence of IPC.
These experiments suggested that upregulation of miR-21
before I/R, such as that induced by IPC, might be required
for the manifestation of the protective effect of miR-21.
DISCUSSION
The present study has revealed a novel in vivo role of a
specific miRNA, miR-21, in the protection against acute
kidney injury conferred by preconditioning. The role of
miRNAs in acute kidney injury is not well understood. Wei
et al.35 demonstrated that mice with broad reductions of
mature miRNAs in the proximal tubule due to Dicer
knockout were more resistant to renal I/R injury. These mice
exhibited better renal function, less renal damage, fewer
apoptotic cells in the kidney, and improved survival following
bilateral I/R. Godwin et al.36 reported differential expression
of several miRNAs following unilateral renal I/R. They went
on to show that, in cultured mouse tubular epithelial cells,
knockdown of miR-21 increased cell death, but overexpres-
sion of miR-21 in these cells did not prevent cell death
following simulated ischemia. We have now shown that
knockdown of miR-21 in mice in vivo at the time of IPC
worsens renal I/R injury induced 4 days later, indicating that
miR-21 contributes to the protection conferred by delayed
IPC. Knockdown of miR-21 in the absence of IPC, however,
did not further exacerbate renal injury. Taken together, these
studies support an important role for miRNAs in the
development of acute kidney injury or the protection from
it. Although Dicer and perhaps certain dominating miRNAs
in the proximal tubule might be pro injury, specific miRNAs
such as miR-21 are protective. Moreover, the protective effect
of miR-21 may depend on the timing and context of injury.
Additional miRNAs may be involved in I/R injury and IPC
but their functional roles in renal I/R injury or IPC remain to
be examined. In studies of renal I/R models by Godwin
et al.35 and Wei et al.,36 several miRNAs such as miR-214,
miR-7, and miR-192 were shown to be upregulated, whereas
others such as miR-322 were downregulated. Ren et al.37 reported
decreases in the level of miR-320 expression and increases in
the levels of miR-7, miR-21, and miR-491 expression in the
mouse heart 24 h after 30-min ischemia. Several miRNAs
were differentially regulated in hippocampi following global
ischemia38 and gracilis muscles in ischemic injury.39 Yin
et al.23 showed that IPC in the heart resulted in upregulated
miR-1, miR-21, and miR-24 expression. Abundance of
miR-23a, miR-326, miR-346, and miR-370 was altered in
hepatic IPC.20 miR-200 and miR-182 were upregulated after
cerebral IPC.21 In the present study, the expression of
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Figure 4 |Role of hypoxia-inducible factor (HIF)-1a in miR-21
upregulation. (a) Nuclear levels of HIF-1a in mouse kidneys were
increased 4 h after ischemic preconditioning (IPC) and persisted 4
days after IPC, compared with sham mice. n¼ 6 per group at each
time point; *Po0.05 vs. sham mice. (b) CoCl2 and (c) hypoxia,
both classical inducers of HIF-1a, upregulated miR-21 in primary
cultures of human renal epithelial (HRE) cells. HRE cells were
treated with CoCl2 at 300 mM for 4 h or incubated in 2% O2
(hypoxia) for 24 h. n¼ 4 per group, *Po0.05 vs. control or
normoxia group. (d) HIF-1a is activated by the CoCl2 treatment.
n¼ 3 per group, *Po0.05 vs. control group. (e) CoCl2-induced
upregulation of miR-21 was abolished by HIF blockade with a
decoy. n¼ 6 per group, *Po0.05 vs. cells treated with the
scrambled control.
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miR-214, miR-320, and let-7e was examined. These miRNAs
tended to be upregulated by renal IPC, but did not reach
statistical significance.
Several studies in cancer and the heart support a strong
prosurvival and antiapoptotic role of miR-21. miR-21 is
upregulated in several types of solid tumors, including breast
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and photographed at  20 magnification. n¼ 4 for the anti-scramble-treated group; n¼ 3 for the anti-miR-21-treated group.
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tumors, colon tumors, and gliomas.6,24,40 miR-21 was found
to be upregulated early after cardiac IPC and to protect
against cardiac I/R injury.32 miR-21 may exert its protective
effect by targeting proapoptotic genes. For example, miR-21
was shown to reduce the death of ischemic cortical neurons
by downregulating the cell death–inducing Fas ligand (FasL)
gene.41 Overexpression of miR-21 in mouse heart inhibited
ischemia-induced upregulation of phosphatase and tensin
homolog deleted on chromosome ten (PTEN) and FasL,
limited infarct size, and attenuated apoptosis.42 PDCD4 is a
confirmed, direct target of miR-21.31,32 The tumor suppres-
sor PDCD4 was originally characterized as an inhibitor of
neoplastic transformation.43 It has been reported that the
activity of activator protein 1, a key signaling molecule that affects
cell apoptosis in response to extracellular stress, was inhibited
by PDCD4.44 miR-21 expression has been shown to be inversely
correlated with PDCD4 expression and/or cellular apoptosis
in the heart,32 in cultured mouse tubular epithelial cells,36
and now in mouse kidneys in vivo in the present study.
miRNA expression could be regulated by transcriptional
factors,45,46 similar to the regulation of protein-coding genes.
HIF is known as an important transcriptional regulator in
cellular response to hypoxia.47 miR-21 has been reported as
one of the hypoxia-regulated miRNAs in cancer cells, and a
predicted HIF-binding site was found B2 kb upstream from
miR-21 transcription start site.34 We found in the present
study that HIF-1a was upregulated in parallel with miR-21 in
the mouse kidney following IPC, and that blockade of HIF
abolished miR-21 upregulation in vitro, demonstrating a
significant role for HIF in the upregulation of miR-21. We
also found that knockdown of miR-21 did not affect I/R
injury in the absence of IPC, suggesting that the protective
effect of miR-21 might depend on HIF-1 induction by IPC.
Additional mechanisms may participate in the regulation of
miR-21. For example, Polytarchou et al.46 found that under
hypoxia the binding of nuclear factor-kB, cyclic adenosine
monophosphate response element binding, and CBP/p300 to
the miR-21 promoter induces miR-21 expression after the
activation of protein kinase Akt2.
Although the protective effect of delayed IPC on cardiac or
brain I/R injury has been extensively studied,17–19 renal
delayed IPC has only been examined in a small number of
studies. Park et al.16 characterized a mouse model in
which prior exposure to 30-min ischemia protected against
a second ischemic insult imposed 8 or 15 days later.
A shorter period of prior ischemia (15 min) was
partially protective against subsequent ischemic injury 8
days later.16 We previously reported that in rats ischemic
pretreatment for 20 min significantly attenuated I/R injury
caused by 40 min of bilateral renal ischemia 4 days later.13
In the current study, we found that 15-min IPC had a
profound protective effect on mouse kidneys exposed to I/R
injury 4 days later. The renal protection conferred by delayed
IPC is likely mediated by several mechanisms. The current
study indicates that miR-21 represents one of the mechan-
isms involved.
MATERIALS AND METHODS
Mouse models of delayed renal IPC and I/R
IPC was induced in 5- to 6-week-old male C57BL/6J mouse kidneys
(The Jackson Laboratory, Bar Harbor, ME). Briefly, mice were
anesthetized with intraperitoneal xylazine (15 mg/kg) and ketamine
(120 mg/kg) mixture. After performing a midline laparotomy,
bilateral renal pedicles were clamped for 15 min using microserrefine
clips (FST, Burlington, MA). Mice were maintained at 37 1C, and the
abdominal cavity was hydrated with saline-moistened gauze. The
kidneys in separate groups of mice were harvested at 4 h, 24 h, and 4
days after the surgery. Sham mice underwent the same surgical
procedures, except that the renal pedicles were not clamped.
For the delayed IPC and I/R model, 4 days after IPC or sham
surgeries, preconditioned mice were subjected to 30-min occlusion
of bilateral renal pedicles, followed by reperfusion for 24 h
or for longer periods as indicated in the Results section. The renal
clamps were removed after the 30-min occlusion and the kidneys
were observed for another minute to ensure reflow, after which the
incision was closed with a 6.0 suture. Additional groups of mice
underwent 30-min ischemia and 24-h reperfusion without IPC.
All animal protocols were approved by the Institutional Animal
Care and Use Committee at the Medical College of Wisconsin.
In vivo miRNA knockdown using LNA-modified anti-miR
LNA-modified anti-scrambled or anti-miR-21 oligonucleotides (Exiqon,
Woburn, MA) were diluted in saline (5 mg/ml),46 and administered
into the tail vein (10 mg/kg) less than 1 h before ischemia surgery.
Analysis of plasma creatinine
Blood samples were taken through cardiac puncture at the indicated
times. Plasma creatinine was measured using the improved Jaffe
method (Quantichrom creatinine Assay Kit, BioAssay Systems,
Hayward, CA).
Histological analysis of renal injury
Kidneys were fixed in 10% formalin and embedded in paraffin.
Histopathological changes were assessed on periodic acid–Schiff-
stained 4-mm-thick sections by scoring tubular cell necrosis or
swelling, interstitial infiltration by multinucleated cells, tubular
casts, and brush border loss in 10 nonoverlapping fields ( 20
magnification) of the corticomedullary junction and outer medulla.
Tissue damage was examined in a blinded manner and scored
according to the severity of changes on a semiquantitative scale,
where 0 indicated no injury, 1 indicated mild injury, 2 indicated
moderate injury, 3 indicated severe injury, and 4 indicated very
severe injury.13
Terminal deoxynucleotidyl transferase–mediated dUTP nick
end labeling (TUNEL) assay
Kidneys were fixed in 10% formalin, embedded in paraffin, and cut
into thin (4 mm) sections. TUNEL assay was used to assess DNA
fragmentation (In Situ Cell Death Detection kit, Roche, South San
Francisco, CA) according to the manufacturer’s protocol. The
number of TUNEL-positive cells and total cell number in kidney
sections were counted under a light microscope. TUNEL-positive
cells were expressed as percentage of total cells.
Taqman real-time PCR
Total RNA from kidney tissue was isolated using Trizol (Invitrogen,
Carlsbad, CA). Expression levels of several miRNAs and mRNAs
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were quantified in total RNA using real-time PCR with the Taqman
chemistry (Applied Biosystems, Carlsbad, CA) as described pre-
viously.48–50 5S and 18S rRNAs were used as internal normalizer for
miRNAs and mRNAs, respectively.
Nuclear protein extraction
The preparation of nuclear extracts from mouse kidney tissue was
performed using the Nuclear Extract Kit from Active Motif,
(Carlsbad, CA). Briefly, the tissue was homogenized in a hypotonic
buffer containing protease and phosphatase inhibitors, dithiothrei-
tol, and detergent, and centrifuged at 14,000 g for 30 s at 4 1C. The
nuclear pellet was resuspended in 50 ml complete lysis buffer,
incubated on ice for 30 min, and centrifuged at 14,000 g for 10 min
at 4 1C. The supernatant contained nuclear protein.
Western blot analysis
The relative abundance of PDCD4, HIF-1a, JNK, and phosphory-
lated JNK was analyzed using western blot analysis similar to what
we described previously.48–50 The primary antibodies anti-PDCD4,
anti-HIF-1a, anti-JNK, and anti-phosphorylated JNK were from
Sigma (St Louis, MO) (P0071, rabbit polyclonal, 1:500 dilution),
Novus Biologicals (Littleton, CO) (NB100-105, mouse monoclonal,
1:500 dilution), and Santa Cruz (Santa Cruz, CA) (sc-571, rabbit
polyclonal immunoglobulin G (IgG), 1:200 dilution; sc-6254, mouse
monoclonal IgG, 1:100 dilution), respectively. The secondary anti-
body was horseradish peroxidase–conjugated anti-rabbit or anti-
mouse IgG from Santa Cruz. Coomassie blue staining of the entire
membrane was used to confirm equal loading on the gel.
Cell culture and hypoxia treatment
Primary HRE cells (Cambrex, Carlsbad, CA) were cultured in renal
epithelial growth medium (Cambrex).51 HRE cells at 60–70%
confluency were exposed to 300mM cobalt chloride for 4 h or a
steady flow of low-oxygen gas mixture (2% O2, 5% CO2, 94% N2) in
a modular incubator chamber (Thermo Scientific, Waltham, MA)
for 24 h.
HIF decoy
Double-stranded oligodeoxynucleotides containing a hypoxia-re-
sponsive element were used as a decoy to block the activity of
endogenous HIF transcriptional factor. The HIF decoy sequences
were 50-GCCCTACGTGCTGTCTCA-30 (sense) and 50-TGAGACAG
CACGTAGGGC-30 (antisense). The scrambled oligonucleotides
were 50-GCCCTTACAACTGTCTCA-30 (sense) and 50-GAGACAG
TTGTAAGGGC-30 (antisense). Sense and antisense oligonucleotides
were heated at 95 1C for 5 min and then cooled down slowly to room
temperature.52,53 The double-stranded oligonucleotides were trans-
fected into HRE cells at a final concentration of 40 nM for 4 h using
Lipofectamine 2000 (Invitrogen). The cells were then exposed to
300mM cobalt chloride for another 4 h.
Statistics
Data were analyzed using the Student’s t-test when comparing
two groups and two-way analysis of variance followed by
Bonferroni t-test for the time-course data. Real-time PCR data
were shown as percentage of control because data from multiple
PCR plates were combined. For these data, statistical analysis was
performed on the original data before conversion to percentage
values. Po0.05 was considered significant. Data are shown as
mean±s.e.m.
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